dues had very little effect on acquired rifampicin resistance, each mutation made in the C terminus dramati- . Earlier analyretained more than 60% of the antiviral activity of the ses of APOBEC-1 have defined specific residues that wild-type protein under the experimental conditions are important for zinc coordination, proton transfer, used here. Additionally, each mutant was examined for and, therefore, catalysis within this motif [15] . Because activity against wild-type HIV-1; all exhibited Vif-sensi-APOBEC3G contains two such motifs, we used sitetivity and were therefore unable to suppress wild-type directed mutagenesis of conserved residues to assess virion infectivity significantly. Analyzed together with the each region's contribution to anti-HIV-1 activity. Surbacterial editing assay, this rather unexpected result prisingly, whereas either the N-or C-terminal domain suggests that impairment of the editing function of APOcould confer antiviral function in tissue culture-based BEC3G does not necessarily inhibit APOBEC3G's ability infectivity assays, only an intact C-terminal motif was to suppress HIV-1 infection in this context. essential for DNA mutator activity. These findings reWhen the double point mutant proteins were examveal the nonequivalency of APOBEC3G's N-and ined for their effects on infectivity, the loss of APO-C-terminal domains and imply that APOBEC3G-medi-BEC3G function was far more dramatic. In fact, the obated DNA editing may not always be necessary for served loss of activity for each double mutant exceeded antiviral activity. Accordingly, we propose that APOwhat might be expected from the corresponding single BEC3G can achieve an anti-HIV-1 effect through an point mutant data. For example, whereas E67Q and undescribed mechanism that is distinct from cytidine E259Q each retain 80%-90% antiviral activity, the corredeamination.
Table 1. Summary of APOBEC3G Mutations

Consensus: H-(A/V)-E-(X) 24-30 -P-C-(X)2-C N-Terminal Active Site
C-Terminal Active Site aa Change
H-P-E-(X) 24-30 -P-C-(X) 2 -C H-A-E-(X) 24-30 -P-C-(X) 2 -C
Wild-type R-P-E-(X) 24-30 -P-C-(X) 2 -C H-A-E-(X) 24-30 -P-C-(X) 2 -C H65R H-P-E-(X) 24-30 -P-C-(X) 2 -C R-A-E-(X) 24-30 -P-C-(X) 2 -C H257R R-P-E-(X) 24-30 -P-C-(X) 2 -C R-A-E-(X) 24-30 -P-C-(X) 2 -C H65R and H257R H-P-Q-(X) 24-30 -P-C-(X) 2 -C H-A-E-(X) 24-30 -P-C-(X) 2 -C E67Q H-P-E-(X) 24-30 -P-C-(X) 2 -C H-A-Q-(X) 24-30 -P-C-(X) 2 -C E259Q H-P-Q-(X) 24-30 -P-C-(X) 2 
-C H-A-Q-(X) 24-30 -P-C-(X) 2 -C E67Q and E259Q H-P-E-(X) 24-30 -P-S-(X) 2 -C H-A-E-(X) 24-30 -P-C-(X) 2 -C C97S H-P-E-(X) 24-30 -P-C-(X) 2 -C H-A-E-(X) 24-30 -P-S-(X) 2 -C C288S H-P-E-(X) 24-30 -P-S-(X) 2 -C H-A-E-(X) 24-30 -P-S-(X) 2 -C C97S and C288S H-P-E-(X) 24-30 -P-C-(X) 2 -S H-A-E-(X) 24-30 -P-C-(X) 2 -C C100S H-P-E-(X) 24-30 -P-C-(X) 2 -C H-A-E-(X) 24-30 -P-C-(X) 2 -S C291S H-P-E-(X) 24-30 -P-C-(X) 2 -S H-A-E-(X) 24-30 -P-C-(X) 2 -S C100S and C291S
The consensus sequence of the active site for cytidine deaminases is shown at the top. Mutations were made with oligonucleotide sitedirected mutagenesis (Invitrogen). The underlined letters indicate the change in amino acid for the corresponding mutant.
tions identified in cloned cDNAs are catalogued in Figure 1A ), we fore, although the cytidine deaminase activity of the C-terminal mutants is not required for their ability to were unable to detect any significant mutational activity in any of the infections carried out in the presence of suppress virion infectivity, we were unable to dissociate the ability of these proteins to be packaged into assemthe C-terminal mutants (Table 2) , despite the fact that these proteins displayed strong antiviral effects, ranging bling virions from their antiviral function. Finally, it could be argued that editing-deficient APOBEC3G mutants from 53%-97% ( Figure 1B ; Table 2 ). These data suggest that an antiviral function of APOBEC3G can be exerted interfere with infection in a more fundamental manner than the wild-type protein (for instance, by severely diindependently of its DNA deaminase activity.
We considered the possibility that disruption of the minishing reverse transcription). We consider this explanation to be unlikely: First, extensively edited reverse C-terminal active site created mutant proteins in which this domain acquired a dominant-interfering phenotype transcripts were still readily recovered in the mixing experiment discussed earlier (Table S1) , and second, preover the N-terminal site, such that the assumed lack of enzymatic activity of the N-terminal site was, instead, liminary measurements of viral cDNA levels indicate that the early phases of reverse transcription are as efficient due to suppression. Recently, a number of groups have experimentally shown the dimerization capabilities of in the presence of these C-terminal mutants as they are with wild-type APOBEC3G (data not shown). several APOBEC family members [19] [20] [21] . We exploited these observations to ask whether mutant carboxy-terPrevious reports of APOBEC3G-induced hypermutation have correlated cytidine deaminase activity with minal domains can influence the activity of editingactive domains that may be in close spatial proximity. antiviral function [3, 5, 26]. Our results with cultured cell systems and a panel of mutant APOBEC3G proteins Expression constructs for wild-type APOBEC3G and the E259Q mutant were cotransfected (at a 1:6 ratio) into indicate that this is not always the case. In particular, we demonstrate that, under the described experimental 293T cells, and both virion infectivity and cDNA editing capacity were examined (see Table S1 in the Suppleconditions, the cytidine deamination function of APO-BEC3G can be separated from antiviral activity. We note mental Data available with this article online). The presence of the E259Q protein had no effect on the extent of that our study differs from these earlier reportings in that we employed proteins that had not been epitope editing mediated by the wild-type APOBEC3G protein, arguing against the idea of a dominant-negative effect.
tagged. In our experience, we have observed that a terminal tag can not only interfere with mutant protein Because the C-terminal mutants fail to edit viral cDNA in target cells, we questioned whether this protein was expression but can impair function in the E. coli-based assay and during virus infection (unpublished data). Our still packaged into HIV-1 virions. In APOBEC-1, several residues within the active site have been shown to also data raise the possibility that the APOBEC3G-induced viral-cDNA hypermutation that has been observed by be critical for RNA binding [15] . If these conserved residues within the C-terminal active site of APOBEC3G many groups may be an observable side effect and may not always be central to the antiviral function of play a similar role, then their replacement could also influence RNA binding, an attribute that has been re-APOBEC3G. In other words, the finding that APOBEC3G Figure 1B ). Viral supernatants were harvested at 24 hr after transfection, and virions were isolated by continuous sucrose gradient purification [1]. E67Q and E259Q were also packaged to similar levels (data not shown). The lower panels are immunoblots probed with an antibody specific for p24
Gag (loading control).
